menu search

Alaunos Therapeutics Reports First Quarter 2023 Financial Results

Alaunos Therapeutics Reports First Quarter 2023 Financial Results
Actively enrolling patients and manufacturing cryopreserved products for TCR-T Library Phase 1/2 trial; expect to report interim data in the third quarter of 2023 Fully prepaid loan with Silicon Valley Bank; now a debt-free company Amended exclusive licensing agreement with Precigen, Inc., reflecting the Company’s focus on its TCR-T programs and eliminating long-term financial obligations […] The post Alaunos Therapeutics Reports First Quarter 2023 Financial Results appeared first on ForexTV... Read More
Posted: May 10 2023, 11:00
Author Name: forextv
Views: 102224

Search within

Pages Search Results: